Olmesartan Medoxomil: all 45 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationNCT07547878Phase 4
• Angiotensin II Blockade and Inflammation in ObesityCompletedNCT01684748Phase 4Results posted
• Olmesartan Comparison to Losartan in Hypertensive SubjectsCompletedNCT00949884Phase 4Results posted
• Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in HypertensionCompletedNCT00923091Phase 3Results posted
• Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in HypertensionCompletedNCT00902538Phase 3Results posted
• Olmesartan Medoxomil Versus Losartan in Patients With HypertensionCompletedNCT00857285Phase 3Results posted
• A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood PressureCompletedNCT00791258Phase 4Results posted
• Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionCompletedNCT00649389Phase 3Results posted
• Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II HypertensionCompletedNCT00527514Phase 3Results posted
• Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential HypertensionCompletedNCT00430508Phase 3Results posted
• An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With HypertensionCompletedNCT00412932Phase 4Results posted
• An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II DiabetesCompletedNCT00403481Phase 4Results posted
• Olmesartan Pediatric Pharmacokinetic (PK) StudyCompletedNCT00151814Phase 1Results posted
• Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood PressureCompletedNCT00151775Phase 2/3Results posted
• ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy TrialCompletedNCT00141453Phase 3Results posted
• The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.CompletedNCT03951051Phase 1
• Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnNCT02493322Phase 3
• Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension ControlWithdrawnNCT02483936Phase 3
• Lowering Blood Pressure in Primary Care in ViennaCompletedNCT02377661Phase 4
• Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)Status unknownNCT02360956Phase 4
• Drug Interaction Study of Olmesartan in Healthy Chinese VolunteersCompletedNCT01907373Phase 4
• Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male VolunteersCompletedNCT01415466Phase 1
• Telmisartan, Amlodipine and Flow Mediated DilationStatus unknownNCT01180205Phase 4
• The Confirmatory Olmesartan Plaque Regression StudyTerminatedNCT01132768Phase 4
• Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic NephropathyCompletedNCT00914524Phase 2
• Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT00872586Phase 3
• Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential HypertensionCompletedNCT00856271Phase 3
• Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial ProtectionCompletedNCT00676845Phase 3
• Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedNCT00649623Phase 1
• Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mgCompletedNCT00648219Phase 1
• The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)CompletedNCT00607035Phase 4
• Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using OlmesartanCompletedNCT00417222Phase 3
• A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established AtherosclerosisCompletedNCT00382213Phase 3
• Olmesartan Medoxomil and Diabetic NephropathyCompletedNCT00362960Phase 3
• Olmesartan as an add-on to Amlodipine in HypertensionCompletedNCT00220233Phase 3
• Amlodipine as add-on to Olmesartan in HypertensionCompletedNCT00220220Phase 3
• Olmesartan Medoxomil in AtherosclerosisCompletedNCT00185185Phase 3
• Olmesartan in Essential HypertensionCompletedNCT00185172Phase 3
• Olmesartan Medoxomil in Diabetes MellitusCompletedNCT00185159Phase 3
• Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe HypertensionCompletedNCT00185133Phase 3
• Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel BlockerCompletedNCT00185120Phase 4
• A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to InsulinCompletedNCT00185094Phase 4
• The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy SubjectsCompletedNCT00185055Phase 4
• Olmesartan Medoxomil in Hypertension and Renal ImpairmentCompletedNCT00151827Phase 3
• OlmeSartan and Calcium Antagonists Randomized (OSCAR) StudyCompletedNCT00134160Phase 4

← Olmesartan Medoxomil overview